|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-4-17
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Treatment of moderate or severe chronic obstructive pulmonary disease (COPD) with combinations of inhaled corticosteroids, long-acting beta-agonists, and long-acting anticholinergic bronchodilators is common but unstudied.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1539-3704
|
|
pubmed:author |
pubmed-author:AaronShawn DSD,
pubmed-author:AnthonyJohnJ,
pubmed-author:BalterMeyerM,
pubmed-author:BishopGrahamG,
pubmed-author:BleskieDominiqueD,
pubmed-author:BourbeauJeanJ,
pubmed-author:Canadian Thoracic Society/Canadian Respiratory Clinical Research...,
pubmed-author:ChapmanKennethK,
pubmed-author:CowieRobertR,
pubmed-author:CoxGerardG,
pubmed-author:DoucetteSteveS,
pubmed-author:FergussonDeanD,
pubmed-author:FieldStephenS,
pubmed-author:FitzGeraldMarkM,
pubmed-author:FordGordonG,
pubmed-author:FoxGeorgeG,
pubmed-author:GoldsteinRogerR,
pubmed-author:HernandezPaulP,
pubmed-author:HirschAndrewA,
pubmed-author:HodderRichardR,
pubmed-author:HoffsteinVictorV,
pubmed-author:MaltaisFrançoisF,
pubmed-author:MarciniukDarcyD,
pubmed-author:MayersIrvinI,
pubmed-author:McCormackDavidD,
pubmed-author:McIvorAndrewA,
pubmed-author:O'DonnellDenisD,
pubmed-author:PrinsHenry BHB,
pubmed-author:RivingtonRobertR,
pubmed-author:RoadJeremyJ,
pubmed-author:SharmaSatS,
pubmed-author:VandemheenKatherine LKL,
pubmed-author:ZamelNoeN
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
17
|
|
pubmed:volume |
146
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
545-55
|
|
pubmed:dateRevised |
2008-1-14
|
|
pubmed:meshHeading |
pubmed-meshheading:17310045-Administration, Inhalation,
pubmed-meshheading:17310045-Adrenergic beta-Agonists,
pubmed-meshheading:17310045-Aged,
pubmed-meshheading:17310045-Albuterol,
pubmed-meshheading:17310045-Androstadienes,
pubmed-meshheading:17310045-Bronchodilator Agents,
pubmed-meshheading:17310045-Cause of Death,
pubmed-meshheading:17310045-Double-Blind Method,
pubmed-meshheading:17310045-Drug Therapy, Combination,
pubmed-meshheading:17310045-Female,
pubmed-meshheading:17310045-Hospitalization,
pubmed-meshheading:17310045-Humans,
pubmed-meshheading:17310045-Male,
pubmed-meshheading:17310045-Middle Aged,
pubmed-meshheading:17310045-Patient Compliance,
pubmed-meshheading:17310045-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:17310045-Quality of Life,
pubmed-meshheading:17310045-Scopolamine Derivatives,
pubmed-meshheading:17310045-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
|
|
pubmed:affiliation |
The Ottawa Health Research Institute and University of Ottawa, Ottawa, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
